Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cells|August 12, 2022
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 InhibitorLuisa Chocarro, Ana Bocanegra, Ester Blanco, et al.
International Journal of Molecular Sciences|June 2, 2021
Understanding LAG-3 SignalingLuisa Chocarro, Ester Blanco, Miren Zuazo, et al.
Journal of Proteome Research|January 18, 2018
Characterization of Macrophage Endogenous S-Nitrosoproteome Using a Cysteine-Specific Phosphonate Adaptable Tag in Combination with TiO<sub>2</sub> ChromatographyMaría Ibáñez-Vea, Honggang Huang, Xabier Martínez de Morentin, et al.
Head & Neck|October 4, 2023
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancerVirginia Arrazubi, Saioa Goñi, Iranzu González-Borja, et al.
Cancers|August 9, 2020
Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT InhibitionHugo Arasanz, Carlos Hernández, Ana Bocanegra, et al.
Oncotarget|August 31, 2015
A core of kinase-regulated interactomes defines the neoplastic MDSC lineageMaria Gato-Cañas, Xabier Martinez de Morentin, Idoia Blanco-Luquin, et al.
EMBO Molecular Medicine|July 6, 2019
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapyMiren Zuazo, Hugo Arasanz, Gonzalo Fernández-Hinojal, et al.
British Journal of Cancer|January 10, 2024
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategiesEster Blanco, Noelia Silva-Pilipich, Ana Bocanegra, et al.
Pageof 5